Emerging inflammatory response biomarkers are developed to predict the survival of patients with cancer, the aim of our study is to establish an inflammation-related nomogram based on the classical predictive biomarkers to predict the survivals of patients with non-small cell lung cancer (NSCLC). | An inflammation-related nomogram for predicting the survival of patients with non-small cell lung cancer after pulmonary lobectomy